Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy

Cancer

Volumn 94, Issue 6, 2002, Pages 1753-1759

  Gruenberger, Thomas ^a   Zhao, Jing ^a   King, Julie ^a   Chung, TengTeng ^a   Clingan, Phil R ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Colorectal carcinoma; Echogenicity; Hepatic artery infusion; Prognosis; Unresectable liver metastases

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; HEPARIN; SODIUM CHLORIDE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; COLORECTAL CARCINOMA; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; INOPERABLE CANCER; INTRAOPERATIVE PERIOD; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR DIFFERENTIATION; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; FLOXURIDINE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037086453     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10386     Document Type: Article

References (32)

1. The natural history ot primary and secondary malignant tumors of the liver. 1. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy
2. Natural history of patients with untreated liver metastases from colorectal cancer
3. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
4. Resection of colorectal liver metastases
5. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history
6. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
7. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization
8. Multiple bilobar liver metastases: Cryotherapy for residual lesions after liver resection
9. Cryotherapy extends the indications for treatment of colorectal liver metastases
10. Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment
11. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
12. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project
13. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta Analysis Project
14. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
15. The blood supply of neoplasms in the liver
16. Regional chemotherapy of colorectal cancer metastatic to the liver
17. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma
18. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil
19. Pharmacologic rationale for regional drug delivery
20. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial
21. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial
22. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
23. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial
24. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
25. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial
26. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver
27. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
28. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial
29. Prognostic factors in patients with colorectal liver metastases undergoing regional chemotherapy
30. Clinical pharmacology of hepatic arterial chemotherapy
31. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement
32. Pretreatment echogenicity of colorectal liver metastases predicts survival after hepatic cryotherapy